Liothyronine-13C6-1
Modify Date: 2024-04-08 21:06:53
Liothyronine-13C6-1 structure
|
Common Name | Liothyronine-13C6-1 | ||
|---|---|---|---|---|
| CAS Number | 1213431-76-5 | Molecular Weight | 656.93 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | 13C6C9H12I3NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 48.2 °F | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
Use of Liothyronine-13C6-1Liothyronine-13C6-1 is a 13C-labeled Liothyronine. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2]. |
| Name | 3,3′,5-Triiodo-L-thyronine-13C6 solution |
|---|
| Description | Liothyronine-13C6-1 is a 13C-labeled Liothyronine. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | 13C6C9H12I3NO4 |
|---|---|
| Molecular Weight | 656.93 |
| Appearance of Characters | liquid |
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
| Flash Point(F) | 48.2 °F |
| Flash Point(C) | 9 °C |
|
Psychometric assessment of the Rat Grimace Scale and development of an analgesic intervention score.
PLoS ONE 9(5) , e97882, (2014) Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measu... |
|
|
Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.
Crit. Rev. Oncol. Hematol. , doi:10.1016/j.critrevonc.2014.04.004, (2014) Arterial thromboembolic events (ATEs) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have emerged as a serious concern, we perform a meta-analysis of randomiz... |
|
|
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
Strahlenther. Onkol. , (2014) The purpose of this study was to analyze the mode of relapse patterns and survival of 209 patients with stage IVA and IVB nasopharyngeal carcinoma (NPC).A total of 209 patients who underwent magnetic ... |